| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/02/2011 | EP1513934B1 Genes and polypeptides relating to human colon cancers |
| 03/02/2011 | EP1456390B1 Expression of protective antigens in transgenic chloroplasts and the production of improved vaccines |
| 03/02/2011 | EP1436403B1 Use of the adenoviral e2 late promoter |
| 03/02/2011 | EP1368456B1 Anti-bacterial vaccine compositions |
| 03/02/2011 | EP1185662B1 Dna vaccines for dogs |
| 03/02/2011 | EP1163337B1 Vascular adhesion molecules and modulation of their function |
| 03/02/2011 | EP1123316B1 Protein engineering |
| 03/02/2011 | EP1100824B1 Compounds with growth hormone releasing properties |
| 03/02/2011 | CN1954068B HLA-binding peptide, precursor thereof, DNA fragment encoding the same and recombinant vector |
| 03/02/2011 | CN1922315B Enzymatic synthesis, modification and decomposition of silicon(IV) compounds and other metal(IV) compounds |
| 03/02/2011 | CN1714150B Genetic products differentially expressed in tumors and the use thereof |
| 03/02/2011 | CN1646157B Multiple and multivalent DNA vaccines in ovo |
| 03/02/2011 | CN1568195B Peptide YY and peptide YY agonists for treatment of metabolic disorders |
| 03/02/2011 | CN1507490B Promoters |
| 03/02/2011 | CN101983206A Methods for generating marker free transgenic plants |
| 03/02/2011 | CN101983068A Novel n-and c-terminal substituted antagonistic analogs of gh-rh |
| 03/02/2011 | CN101983067A Treatment of microbial infections |
| 03/02/2011 | CN101982777A Duck plague virus antigen capturing ELISA method based on anti-recombination UL51 albumen antibody |
| 03/02/2011 | CN101175540B Use of hydrophobin as a phase stabiliser |
| 03/01/2011 | USRE42190 Method of identifying a compound for inhibiting or stimulating human G protein-coupled receptors |
| 03/01/2011 | US7897848 Control of fruit dehiscence in plants by indehiscent1 genes |
| 03/01/2011 | US7897847 Defensin polynucleotides and methods of use |
| 03/01/2011 | US7897844 PUFA polyketide synthase systems and uses thereof |
| 03/01/2011 | US7897842 GnTIII expression in plants |
| 03/01/2011 | US7897839 Methods for modifying plant characteristics |
| 03/01/2011 | US7897837 Generation of plants with improved pathogen resistance |
| 03/01/2011 | US7897760 Comprises transgenic potato which generates starch with modified viscosity and phosphate characteristics; for enhancing quality of paper, cardboard, adhesive, textile, plaster, concrete, fertilizer, medicine and toothpaste; improving animal feeds |
| 03/01/2011 | US7897744 SARS virus nucleotide and amino acid sequences and uses thereof |
| 03/01/2011 | US7897742 Nucleotide sequences coding phospholipase; screening and identifying grampositive mocroorganisms |
| 03/01/2011 | US7897740 Secreted protein called 36P6D5 characteristic of tumors |
| 03/01/2011 | US7897732 Useful in methods for the induction of bone, cartilage and tissue formation, growth and development of the endometrium and in the acceleration of wound healing |
| 03/01/2011 | US7897731 Corticotropin releasing factor 2 receptor agonists |
| 03/01/2011 | US7897729 Polymeric immunoglobulin fusion proteins that target low affinity FcγReceptors |
| 03/01/2011 | US7897727 Bioactive peptide for cell adhesion |
| 03/01/2011 | US7897726 Fluorescent proteins from Aequorea coerulscens and methods for using the same |
| 03/01/2011 | US7897721 Cyclic peptide compositions for treatment of sexual dysfunction |
| 03/01/2011 | US7897647 Useful in extending the in vivo circulating life of biologically active materials; bicine linker allows for the manipulation of the hydrolysis rate of the prodrug, thereby releasing the native entities at various rates in vivo as well as in vitro |
| 03/01/2011 | US7897571 Recombinant lubricin molecules and uses thereof |
| 03/01/2011 | US7897569 Use of HMGB fragments as anti-inflammatory agents |
| 03/01/2011 | US7897567 Methods of protecting against radiation damage using alpha thymosin |
| 03/01/2011 | US7897566 Analogues of GLP-1 |
| 03/01/2011 | US7897562 Apoptosis-inducing agent and method for inducing apoptosis |
| 03/01/2011 | US7897560 Plasma protein affinity tags |
| 03/01/2011 | US7897394 Endoplasmic reticulum localization signals |
| 03/01/2011 | US7897387 Fungal cell wall synthesis gene |
| 03/01/2011 | US7897386 Cell-based assays for G-protein-coupled receptor-mediated activities |
| 03/01/2011 | US7897385 Fluorescent protein |
| 03/01/2011 | US7897371 Using protein kinase inhibitors to treat and prevent glycogen metabolism defects and cell proliferative disorders |
| 03/01/2011 | US7897370 Process for producing HMG-CoA reductase inhibitor |
| 03/01/2011 | US7897358 Canine transient receptor potential V2 (cTRPV2) and methods of screening for TRPV2 channel modulators |
| 03/01/2011 | US7897355 Expression vector comprising nucleotide sequences coding novel gene which is expressed in prostate tissues for use in diagnosis, prognosis, treatment and prevention of cell proliferative disorders; immunotherapy |
| 03/01/2011 | US7897351 Peptides and antibodies to MUC 1 proteins |
| 03/01/2011 | US7897346 Polyamide nucleic acid derivatives and agents, and processes for preparing them |
| 03/01/2011 | US7897343 Propagating attenuated lelystad agent in host cells for use in generating vaccine for prevention and treatment of procine respiratory infection |
| 03/01/2011 | US7897332 Immunoglobulin for detecting lymphadenopathy associated viral infections; immunodiagnostics |
| 03/01/2011 | US7897158 Recombinant toxin fragments |
| 03/01/2011 | US7897157 Polypeptides with a functional binding domain, translocation domain, a therapeutic domain and a non-native protease cleavage site for cleavage in vitro following expression as a single chain; efficient, less dangerous production method; botulinum neurotoxins targeted to specific cell types |
| 03/01/2011 | US7897152 Viral chemokine-antigen fusion proteins |
| 03/01/2011 | US7897151 Anti-IgE vaccines |
| 03/01/2011 | US7897142 Cyclic nonapeptides coupled to a cyanine dye as an imaging contrast agent; monitoring angiogenesis inhibition |
| 03/01/2011 | CA2469154C Cytotoxic protein and utilization thereof |
| 03/01/2011 | CA2400664C A method for generating hypermutable plants |
| 03/01/2011 | CA2339331C Expression and export of angiogenesis inhibitors as immunofusins |
| 03/01/2011 | CA2323525C Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis |
| 03/01/2011 | CA2301709C Epitope-bearing major histocompatibility complex class ii element/immunoglobulin chimeric molecules |
| 03/01/2011 | CA2285026C Method for enhancing expression of a foreign or endogenous gene product in plants |
| 02/28/2011 | CA2713793A1 Molecular weight markers for membrane proteins |
| 02/24/2011 | WO2011022657A1 Purification of vwf for increased removal of non-lipid enveloped viruses |
| 02/24/2011 | WO2011022638A1 Trp inhibitors and uses thereof |
| 02/24/2011 | WO2011022628A1 Methods and compositions for diagnosis of acute myocardial infarction (ami) |
| 02/24/2011 | WO2011022608A2 Functional expression of yeast nitrate transporter (ynt1) in maize to improve nitrate uptake |
| 02/24/2011 | WO2011022597A1 Functional expression of shuffled yeast nitrate transporter (ynti) in maize to improve nitrate uptake under low nitrate environment |
| 02/24/2011 | WO2011022503A1 New astrovirus species |
| 02/24/2011 | WO2011022394A2 Materials and methods for the development of an antigen-specific immune non-responsiveness state |
| 02/24/2011 | WO2011022103A2 Ganglioside epitopes for treating guillain-barre syndrome |
| 02/24/2011 | WO2011021524A1 Peptides inducing adhesive property of lactic acid bacterium and use of same |
| 02/24/2011 | WO2011021210A1 A preparative non-linear gradient based chromatographic method and purified products thereof |
| 02/24/2011 | WO2011021190A1 Plants producing high crop yield |
| 02/24/2011 | WO2011021186A1 Nap alpha-aminoisobutyric acid analog with neuroprotective activity |
| 02/24/2011 | WO2011020866A2 Albumin fused coagulation factors for non-intravenous administration in the therapy and prophylactic treatment of bleeding disorders |
| 02/24/2011 | WO2011020865A1 Apolipoprotein l- i variants and their use |
| 02/24/2011 | WO2011020746A1 Plants having enhanced yield-related traits and a method for making the same |
| 02/24/2011 | WO2011020497A1 C-terminal mutant of apolipoprotein l-i and its therapeutical or prophylactic use |
| 02/24/2011 | WO2011020320A1 Homodimer of insulinotropic peptide analogues and method for preparation thereof and use thereof |
| 02/24/2011 | WO2011020319A1 Fusion protein regulating plasma glucose and lipid, its preparation method and use |
| 02/24/2011 | WO2011020188A1 Peptide sequences and peptide-mediated sirna delivery |
| 02/24/2011 | WO2011020163A1 Plant gene expression |
| 02/24/2011 | WO2011020155A1 Anti p2x7 receptor antibodies and fragments thereof |
| 02/24/2011 | WO2010149792A3 Antimicrobial agents |
| 02/24/2011 | WO2010136492A3 Combination of a tnf-alpha antagonist and a vegf antagonist for use in the treatment or prevention of diseases of the eye. |
| 02/24/2011 | WO2010133834A3 Fviii-derived peptides |
| 02/24/2011 | WO2010117750A3 Engineering broad-spectrum disease resistance against haustorium-forming pathogens using rpw8 as a delivery vehicle |
| 02/24/2011 | WO2010108126A3 Reprogramming compositions and methods of using the same |
| 02/24/2011 | WO2010053772A3 Disease-associated antigens and methods of use thereof |
| 02/24/2011 | WO2010040508A8 Bispecific anti-vegf/anti-ang-2 antibodies |
| 02/24/2011 | WO2010007372A8 Transgenic rodent expressing truncated disc1 |
| 02/24/2011 | WO2009135603A8 Method of generating hypoallergenic glycoproteins in mutated or transgenic plants or plant cells, and mutated or transgenic plants and plant cells for generating hypoallergenic glycoproteins |
| 02/24/2011 | US20110047660 Compositions and related methods for modulating alkaloid production by controlling pmt promoter activation mediated by transcriptional factors erf and myc |
| 02/24/2011 | US20110047657 Method for generating hypoallergenic glycoproteins in mutated or transgenic plants or plant cells, and mutated or transgenic plants and plant cells for generating hypoallergenic glycoproteins |
| 02/24/2011 | US20110047647 Functional expression of shuffled yeast nitrate transporter (ynt1) in maize to improve nitrate uptake under low nitrate environment |